Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss. The company's stock declined 4.12 per cent to Rs 851.50 on the BSE.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/xJq48Ek
https://ift.tt/6pNwqMd
0 Comments